Search

everythinglearnresearchcommunity

for

Search:↓

Onabotulinumtoxin-A effectively treated a painful scalp condition when other treatments failed.

Hair loss after COVID-19 is common, starts sooner in severe cases, and often comes with scalp pain.

The early genes of a specific virus can cause abnormal skin cell growth and hair follicle changes.

Trichodynia is a painful scalp condition needing targeted treatments beyond symptom management.

Many people with hair loss experience scalp pain known as trichodynia, but the causes are unclear and treatments vary.

People with hair loss conditions like Telogen Effluvium and Alopecia Areata often feel scalp pain and are more likely to have anxiety, but not necessarily depression.

Higher levels of certain nerve-related proteins are linked to hair loss in women with scalp pain.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

Hair loss can cause scalp discomfort.

Recombinant keratins can form useful structures for medical applications, overcoming natural keratin limitations.

Trichodynia is a painful scalp condition linked to hair loss and mental health issues, with limited treatment options.

Nearly half of the French individuals surveyed reported having a sensitive scalp, more common in women, often linked to hair loss and symptoms like itching, and triggered by factors including shampoos and pollution.

Notch-related genes play a key role in the development and cycling of hair follicles.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

High glycine–tyrosine keratin-associated proteins help make hair strong and maintain its shape.

Hair loss in secondary syphilis is more common than thought and can be reversed with antibiotics.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

COVID-19 may trigger sudden temporary hair loss.

Hair microscopy is useful for diagnosing hair disorders, but clear definitions are needed for accurate genetic analysis.

The author clarified that Alopecia Areata Incognita (AAI) and diffuse Alopecia Areata (AA) are different conditions and the case discussed was actually AA, not AAI.

Researchers found that the most reachable bonds in wool fibers are near the ends of certain proteins, which help stabilize the fiber's structure.

Low-dose naltrexone might be a cheap and effective additional treatment for hair loss with scalp discomfort due to its anti-inflammatory effects and few side effects.

Some people who got COVID-19 experienced temporary hair loss starting around 10 weeks after infection, with many seeing improvement within about 25 days.

Some hair protein genes evolved early and were adapted for use in hair follicles.

The author clarifies that alopecia areata incognito and diffuse alopecia areata are different types of hair loss with unique symptoms and challenges in diagnosis.

Stopping forehead irritation and using hydrocortisone helped a man's skin, Martinique has lower melanoma rates, a man had an allergy to a specific antifungal, another had unexplained cysts, certain drugs can cause skin reactions without always being interrelated, a link between Fanconi anemia and a skin condition was suggested, high levels of a certain protein may play a role in a type of psoriasis, and there's a need to study the connection between scalp pain and hair loss.

Sensitive scalp causes discomfort and hair loss, treated with personalized care.

The treatment with an oral drug and topical lotion is effective and well-tolerated for hair loss after COVID-19.